Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | thioredoxin reductase | 0.0055 | 0.0321 | 0.023 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0094 | 0.0168 |
Chlamydia trachomatis | sulfite reductase | 0.0227 | 0.1879 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0055 | 0.0321 | 0.0745 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0141 | 0.1099 | 0.5 |
Mycobacterium tuberculosis | Probable reductase | 0.0124 | 0.0953 | 0.8562 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0141 | 0.1099 | 0.5 |
Trypanosoma cruzi | oxidoreductase-protein, putative | 0.0042 | 0.0206 | 0.0367 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0055 | 0.0321 | 0.0745 |
Plasmodium vivax | oxidoreductase NAD-binding domain containing protein | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Onchocerca volvulus | 0.0538 | 0.4683 | 1 | |
Plasmodium vivax | flavodoxin domain containing protein | 0.0326 | 0.2771 | 0.8764 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0055 | 0.0321 | 0.0371 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0368 | 0.3149 | 0.572 |
Trypanosoma brucei | oxidoreductase-protein, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0051 | 0.0292 | 0.0275 |
Onchocerca volvulus | 0.0068 | 0.0441 | 0.0523 | |
Trypanosoma cruzi | p450 reductase, putative | 0.0368 | 0.3149 | 1 |
Leishmania major | NADH-dependent fumarate reductase-like protein | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0141 | 0.1099 | 0.3289 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0326 | 0.2771 | 0.4667 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0368 | 0.3149 | 1 |
Toxoplasma gondii | NADH-cytochrome b5 reductase 1, putative | 0.0042 | 0.0206 | 0.0812 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0124 | 0.0953 | 0.8562 |
Brugia malayi | flavodoxin family protein | 0.0141 | 0.1099 | 0.1959 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0055 | 0.0321 | 0.0371 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0141 | 0.1099 | 0.3289 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0368 | 0.3149 | 1 |
Brugia malayi | Serotonin/octopamine receptor family protein 7 | 0.064 | 0.5608 | 1 |
Echinococcus multilocularis | geminin | 0.0386 | 0.3318 | 1 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Loa Loa (eye worm) | hypothetical protein | 0.064 | 0.5608 | 0.5567 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0368 | 0.3149 | 1 |
Loa Loa (eye worm) | diaphorase | 0.0042 | 0.0206 | 0.0113 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | oxidoreductase-like protein | 0.0042 | 0.0206 | 0.0367 |
Brugia malayi | Thioredoxin reductase | 0.0055 | 0.0321 | 0.0573 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0141 | 0.1099 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0386 | 0.3318 | 0.576 |
Brugia malayi | Pre-SET motif family protein | 0.0472 | 0.4094 | 0.73 |
Brugia malayi | FAD binding domain containing protein | 0.0227 | 0.1879 | 0.335 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0185 | 0.1501 | 0.2398 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0368 | 0.3149 | 0.9458 |
Plasmodium falciparum | glutathione reductase | 0.0055 | 0.0321 | 0.0745 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0051 | 0.0292 | 0.052 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0141 | 0.1099 | 0.5 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0068 | 0.0441 | 0.2507 |
Trypanosoma cruzi | p450 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0068 | 0.0441 | 0.0753 |
Plasmodium falciparum | thioredoxin reductase | 0.0055 | 0.0321 | 0.0745 |
Plasmodium vivax | hypothetical protein, conserved | 0.0141 | 0.1099 | 0.3289 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0141 | 0.1099 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0292 | 0.0158 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0051 | 0.0292 | 0.0275 |
Plasmodium falciparum | ferredoxin--NADP reductase | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | hypothetical protein, conserved | 0.0141 | 0.1099 | 0.3289 |
Toxoplasma gondii | ferredoxin NADP+ oxidoreductase FNR | 0.0042 | 0.0206 | 0.0812 |
Plasmodium vivax | ferredoxin--NADP reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus granulosus | geminin | 0.0386 | 0.3318 | 1 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0051 | 0.0292 | 0.0275 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0368 | 0.3149 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0368 | 0.3149 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0068 | 0.0441 | 0.0434 |
Echinococcus granulosus | methionine synthase reductase | 0.0227 | 0.1879 | 0.5376 |
Trypanosoma brucei | nitrate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus multilocularis | methionine synthase reductase | 0.0227 | 0.1879 | 0.5376 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0124 | 0.0953 | 0.8562 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0124 | 0.0953 | 0.8562 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0472 | 0.4094 | 0.4038 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0368 | 0.3149 | 0.9458 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0368 | 0.3149 | 0.9458 |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.064 | 0.5608 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0051 | 0.0292 | 0.0275 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0326 | 0.2771 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0386 | 0.3318 | 0.576 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0138 | 0.1078 | 1 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.0042 | 0.0206 | 0.0368 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0182 | 0.1476 | 1 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0068 | 0.0441 | 0.0753 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0068 | 0.0441 | 0.0434 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.0042 | 0.0206 | 0.0367 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0138 | 0.1078 | 1 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0141 | 0.1099 | 0.3289 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.0042 | 0.0206 | 0.0113 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | trypanothione reductase | 0.0055 | 0.0321 | 0.0745 |
Trichomonas vaginalis | set domain proteins, putative | 0.0538 | 0.4683 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0068 | 0.0441 | 0.0785 |
Plasmodium vivax | glutathione reductase, putative | 0.0055 | 0.0321 | 0.0745 |
Trypanosoma brucei | trypanothione reductase | 0.0055 | 0.0321 | 0.0745 |
Loa Loa (eye worm) | glutathione reductase | 0.0055 | 0.0321 | 0.023 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | cytochrome-b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0141 | 0.1099 | 0.3289 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0368 | 0.3149 | 1 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0292 | 0.0158 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0042 | 0.0206 | 0.0367 |
Brugia malayi | flavodoxin family protein | 0.0368 | 0.3149 | 0.5615 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0068 | 0.0441 | 0.0434 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0182 | 0.1476 | 0.2351 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0055 | 0.0321 | 0.1322 |
Trypanosoma cruzi | nitrate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0068 | 0.0441 | 0.0753 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0141 | 0.1099 | 0.1014 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | nitrate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | cytochrome P450 reductase, putative | 0.0326 | 0.2771 | 0.8764 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0368 | 0.3149 | 0.3084 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Toxoplasma gondii | thioredoxin reductase | 0.0055 | 0.0321 | 0.1646 |
Leishmania major | p450 reductase, putative | 0.0368 | 0.3149 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0368 | 0.3149 | 1 |
Plasmodium vivax | SET domain protein, putative | 0.0068 | 0.0441 | 0.1134 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0182 | 0.1476 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0292 | 0.0158 |
Leishmania major | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | NADH-cytochrome b5 reductase-like protein | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Plasmodium falciparum | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0068 | 0.0441 | 0.0434 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.0441 | 0.035 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0065 | 0.0418 | 0.0681 |
Giardia lamblia | Hypothetical protein | 0.0326 | 0.2771 | 1 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0141 | 0.1099 | 0.3289 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0141 | 0.1099 | 0.3289 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0227 | 0.1879 | 0.1802 |
Brugia malayi | glutathione reductase | 0.0055 | 0.0321 | 0.0573 |
Brugia malayi | FAD binding domain containing protein | 0.0368 | 0.3149 | 0.5615 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0368 | 0.3149 | 0.9458 |
Treponema pallidum | flavodoxin | 0.0141 | 0.1099 | 1 |
Trypanosoma cruzi | reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0368 | 0.3149 | 1 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0227 | 0.1879 | 0.3096 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0124 | 0.0953 | 0.8562 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0368 | 0.3149 | 1 |
Brugia malayi | diaphorase | 0.0042 | 0.0206 | 0.0368 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0051 | 0.0292 | 0.02 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.0042 | 0.0206 | 0.0367 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0124 | 0.0953 | 0.8562 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0368 | 0.3149 | 0.5447 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0138 | 0.1078 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0368 | 0.3149 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0138 | 0.1078 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0368 | 0.3149 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0368 | 0.3149 | 0.3084 |
Leishmania major | cytochrome-b5 reductase, putative | 0.0042 | 0.0206 | 0.0367 |
Loa Loa (eye worm) | hypothetical protein | 0.064 | 0.5608 | 0.5567 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.